Insights for Navigating an Uncertain World
“The U.S. Food and Drug Administration authorized a third COVID shot for immunocompromised patients. The Pfizer and Moderna vaccines have not been fully approved, and neither company has completed late-stage clinical trials proving a third dose will work.”
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts